Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Lower net acquisition costs for GLP-1 medications would strengthen the economic case for maintaining or adding GLP-1 coverage for obesity
Novo Nordisk shares in hot water after disappointing trial Investors who had hopes that Novo Nordisk (NVO) could succeed outside of weight-loss drugs were disappointed on Friday, July 31
Always follow your MEDVi provider's guidance
CCH is an injectable drug, first of its class, and is composed of two purified bacterial collagenases (AUX-I and AUX-II [Clostridial class I and II collagenases]) that hydrolyze Type I and III collagen with high specificity under physiologic conditions, resulting in disruption of targeted collagen structures found within the septae of cellulite
US$ 23.32
US$ 22.68
US$ 26.43
US$ 25.01
